Over the last few years, with fears increased in the healthcare industry that its top executives could be targets of violence ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing. The CEO's ...

Three dividend stocks that are near their 52-week lows and which may make for solid income-generating investments are Pfizer ...

(Reuters) -Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation ...

The video of him saying this was altered. We’ve seen another example of a video on Facebook that has been edited to make it sound as though Albert Bourla, the chairman and CEO of the drug company ...

China is prepared for “possible unexpected shocks,” Premier Li Qiang told a gathering of global executives in Beijing, where ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Visitors find China "is not what the media describes," Chinese Consul General in New York Chen Li said in an interview. "It’s ...

The city’s pharma giants avoided much of the initial turbulence felt by the rest of the economy in the wake of President ...

Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector ...